Mihael H. Polymeropoulos

2019

In 2019, Mihael H. Polymeropoulos earned a total compensation of $4.3M as President and Chief Executive Officer at Vanda Pharmaceuticals, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$675,000
Option Awards$1,610,154
Salary$721,000
Stock Awards$1,237,200
Other$34,783
Total$4,278,137

Polymeropoulos received $1.6M in option awards, accounting for 38% of the total pay in 2019.

Polymeropoulos also received $675K in non-equity incentive plan, $721K in salary, $1.2M in stock awards and $34.8K in other compensation.

Rankings

In 2019, Mihael H. Polymeropoulos' compensation ranked 2,742nd out of 13,971 executives tracked by ExecPay. In other words, Polymeropoulos earned more than 80.4% of executives.

ClassificationRankingPercentile
All
2,742
out of 13,971
80th
Division
Manufacturing
988
out of 5,701
83rd
Major group
Chemicals And Allied Products
326
out of 2,200
85th
Industry group
Drugs
265
out of 1,886
86th
Industry
Pharmaceutical Preparations
195
out of 1,398
86th
Source: SEC filing on April 22, 2020.

Polymeropoulos' colleagues

We found four more compensation records of executives who worked with Mihael H. Polymeropoulos at Vanda Pharmaceuticals in 2019.

2019

Gian Reverberi

Vanda Pharmaceuticals

Former Senior Vice President, Chief Commercial Officer

2019

James Kelly

Vanda Pharmaceuticals

Chief Financial Officer

2019

Timothy Williams

Vanda Pharmaceuticals

General Counsel

2019

Gunther Birznieks

Vanda Pharmaceuticals

Senior Vice President, Business Development

News

You may also like